Literature DB >> 10853827

Endochondral bone formation in toothless (osteopetrotic) rats: failures of chondrocyte patterning and type X collagen expression.

S C Marks1, C Lundmark, C Christersson, T Wurtz, P R Odgren, M F Seifert, C A Mackay, A Mason-Savas, S N Popoff.   

Abstract

The pacemaker of endochondral bone growth is cell division and hypertrophy of chondrocytes. The developmental stages of chondrocytes, characterized by the expression of collagen types II and X, are arranged in arrays across the growth zone. Mutations in collagen II and X genes as well as the absence of their gene products lead to different, altered patterns of chondrocyte stages which remain aligned across the growth plate (GP). Here we analyze GP of rats bearing the mutation toothless (tl) which, apart from bone defects, develop a progressive, severe chondrodystrophy during postnatal weeks 3 to 6. Mutant GP exhibited disorganized, non-aligned chondrocytes and mineralized metaphyseal bone but without cartilage mineralization or cartilaginous extensions into the metaphysis. Expression of mRNA coding for collagen types II (Col II) and X (Col X) was examined in the tibial GP by in situ hybridization. Mutant rats at 2 weeks exhibited Col II RNA expression and some hypertrophied chondrocytes (HC) but no Col X RNA was detected. By 3rd week, HC had largely disappeared from the central part of the mutant GP and Col II RNA expression was present but weak and in 2 separate bands. Peripherally the GP contained HC but without Col X RNA expression. This abnormal pattern was exacerbated by the fourth week. Bone mineralized but cartilage in the GP did not. These data suggest that the tl mutation involves a regulatory function for chondrocyte maturation, including Col X RNA synthesis and mineralization, and that the GP abnormalities are related to the Col X deficiency. The differences in patterning in the tl rat GP compared to direct Col X mutations may be explained by compensatory effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853827

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  6 in total

1.  The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification.

Authors:  Liesbeth Van Wesenbeeck; Paul R Odgren; Carole A MacKay; Marina D'Angelo; Fayez F Safadi; Steven N Popoff; Wim Van Hul; Sandy C Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

2.  Expression of Ten-m/Odz3 in the fibrous layer of mandibular condylar cartilage during postnatal growth in mice.

Authors:  Takashi Murakami; Tomohiro Fukunaga; Nobuo Takeshita; Koichi Hiratsuka; Yoshimitsu Abiko; Takashi Yamashiro; Teruko Takano-Yamamoto
Journal:  J Anat       Date:  2010-07-15       Impact factor: 2.610

3.  Spatial periodicity in growth plate shear mechanical properties is disrupted by vitamin D deficiency.

Authors:  Derin Sevenler; Mark R Buckley; Grace Kim; Marjolein C H van der Meulen; Itai Cohen; Lawrence J Bonassar
Journal:  J Biomech       Date:  2013-05-21       Impact factor: 2.712

4.  RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.

Authors:  Min Seuk Kim; Yu-Mi Yang; Aran Son; Yu Shun Tian; Syng-Ill Lee; Sang Won Kang; Shmuel Muallem; Dong Min Shin
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

5.  5-Androstene-3β,7β,17β-triol (β-AET) slows thermal injury induced osteopenia in mice: relation to aging and osteoporosis.

Authors:  Ajay K Malik; Sophia Khaldoyanidi; Dominick L Auci; Scott C Miller; Clarence N Ahlem; Christopher L Reading; Theodore Page; James M Frincke
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

6.  Evolution of the osteoblast: skeletogenesis in gar and zebrafish.

Authors:  B Frank Eames; Angel Amores; Yi-Lin Yan; John H Postlethwait
Journal:  BMC Evol Biol       Date:  2012-03-05       Impact factor: 3.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.